Haemonetics Corp (STU:HAZ)
€ 78.5 +0.50 (+0.64%) Market Cap: 3.58 Bil Enterprise Value: 4.41 Bil PE Ratio: 44.51 PB Ratio: 4.93 GF Score: 85/100

Q2 2026 Haemonetics Corp Earnings Call Transcript

Nov 6, 2025 / 01:00 PM GMT
Release Date Price: €43.4 (+0.46%)

Key Points

Positve
  • Haemonetics Corp (HAE) reported strong organic growth of 9% in the quarter and 11% year-to-date, excluding portfolio transitions.
  • Adjusted EPS increased by 13% in the quarter and 11% year-to-date, indicating strong profitability.
  • The company achieved record margin expansion, with adjusted gross margin reaching 60.5% in the second quarter.
  • Plasma business showed robust growth with a 19% organic revenue increase in the quarter, driven by share gains and innovation.
  • Haemonetics Corp (HAE) raised its full-year revenue guidance, reflecting better-than-expected performance across 80% of its portfolio.
Negative
  • Reported revenue declined by 5% due to portfolio transitions, impacting overall growth figures.
  • Interventional technologies saw a decline of 5% in the quarter, with esophageal cooling being a significant underperformer.
  • Blood Center reported an 18% decline in revenue due to the whole blood divestiture.
  • The company faces competitive pressures in the vascular closure market, impacting growth in that segment.
  • Despite strong plasma performance, the guidance remains cautious due to factors outside the company's control, such as collection volumes.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

HAE.N - Haemonetics Corp
Q2 2026 Haemonetics Corp Earnings Call
Nov 06, 2025 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and thank you for standing by. Welcome to the second quarter 2026 Hamanetics Corporation earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press 11 again.

Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Olga Gayle, Vice President, Investor Relations and Treasurer.

Please go ahead.

------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot